This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Phase III of ADT +/- Local RT +/- Abiraterone Ac...
Clinical trial

A Phase III of ADT +/- Local RT +/- Abiraterone Acetate in Metastatic Hormone-na�ve Prostate Cancer. (PEACE1)

Read time: 1 mins
Last updated:24th Sep 2013
This is a multi-center phase III study to compare the clinical benefit of androgen deprivation therapy with or without local radiotherapy with or without abiraterone acetate and prednisone in patient with metastatic hormone-naïve prostate cancer.
Category Value
Study start date 2013-09-24

View full details